ArticleAvicenna journal of phytomedicine
Article in Avicenna journal of phytomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Erectile dysfunction (ED) is a prevalent complication among diabetic patients, and it is associated with oxidative stress, endothelial dysfunction, and diminished nitric oxide generation. This study investigates the therapeutic efficacy of alkaloid extracts from Materials and Methods: Male Wistar rats were divided into seven groups: non-diabetic control, untreated diabetic, standard drug-treated diabetic (5 mg/kg glibenclamide), and four extract-treated diabetic groups (5 and 50 mg/kg of each plant alkaloid extract). Diabetes was induced via intraperitoneal injection of streptozotocin (STZ). Treatments were administered orally, once daily, for a duration of 21 days. Results: Biochemical analysis demonstrated that diabetic rats had elevated phosphodiesterase-5 (PDE-5) and arginase activities and diminished antioxidant molecules. Treatment with plant extracts significantly inhibited PDE-5 and arginase activities, restored antioxidant enzymes (superoxide dismutase, catalase, glutathione-S-transferase, and reduced glutathione), and decreased malondialdehyde (MDA) and reactive oxygen species levels, indicating their potential to mitigate oxidative stress. The extracts had an inhibitory effect on acetylcholinesterase and butyrylcholinesterase activities, hence augmenting cholinergic signaling. Conclusion: Alkaloid extracts of
Indexed as
Identifiers
41509119PMC12777674What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.